73 related articles for article (PubMed ID: 3428124)
21. Ethanol-stimulated behaviour in mice is modulated by brain catalase activity and H2O2 rate of production.
Pastor R; Sanchis-Segura C; Aragon CM
Psychopharmacology (Berl); 2002 Dec; 165(1):51-9. PubMed ID: 12474118
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
Mimnaugh EG; Gram TE; Trush MA
J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
[TBL] [Abstract][Full Text] [Related]
23. Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
Doroshow JH
Cancer Res; 1983 Feb; 43(2):460-72. PubMed ID: 6293697
[TBL] [Abstract][Full Text] [Related]
24. Catalase activity in red cell and liver of mice infected with Plasmodium berghei.
Areekul S; Boonme Y
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):48-52. PubMed ID: 3526580
[TBL] [Abstract][Full Text] [Related]
25. Discrepancy between the different subcellular activities of rat liver catalase and superoxide dismutases in response to acute ethanol administration.
Ribière C; Sinaceur J; Nordmann J; Nordmann R
Alcohol Alcohol; 1985; 20(1):13-8. PubMed ID: 4040372
[TBL] [Abstract][Full Text] [Related]
26. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
27. [Effect of ethanol and the catalase inhibitor aminotriazole on lipid peroxidation in the rat myocardium].
Panchenko LF; Pirozhkov SV; Popova SV; Antonenkov VD
Biull Eksp Biol Med; 1987 Apr; 103(4):407-10. PubMed ID: 3567333
[TBL] [Abstract][Full Text] [Related]
28. Metallothionein induction in the liver, kidney, heart and aorta of cadmium and isoproterenol treated rats.
Bobillier-Chaumont S; Maupoil V; Berthelot A
J Appl Toxicol; 2006; 26(1):47-55. PubMed ID: 16158394
[TBL] [Abstract][Full Text] [Related]
29. Partial purification and properties of bovine heart catalase.
Tsutsui K; Hatase O; Oda T
Acta Med Okayama; 1979 Apr; 33(2):103-11. PubMed ID: 157668
[TBL] [Abstract][Full Text] [Related]
30. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
31. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice.
Bruynzeel AM; Vormer-Bonne S; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2007 Sep; 60(4):509-14. PubMed ID: 17177067
[TBL] [Abstract][Full Text] [Related]
33. Conjugated dienes in selected organs of mice treated with doxorubicin and 4'-epi-doxorubicin. Part I.
Drzewoski J; Pierściński G; Nowak D
Pol J Pharmacol; 1994; 46(1-2):51-4. PubMed ID: 7981771
[TBL] [Abstract][Full Text] [Related]
34. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
35. Erythrocyte catalase decreases cardiac reperfusion injury.
Brown JM; Grosso MA; Banerjee A; Whitman GJ; Repine JE; Harken AH
Curr Surg; 1989; 46(2):122-4. PubMed ID: 2736964
[No Abstract] [Full Text] [Related]
36. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity.
Singh G; Singh AT; Abraham A; Bhat B; Mukherjee A; Verma R; Agarwal SK; Jha S; Mukherjee R; Burman AC
J Ethnopharmacol; 2008 Apr; 117(1):123-9. PubMed ID: 18346858
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Childs AC; Phaneuf SL; Dirks AJ; Phillips T; Leeuwenburgh C
Cancer Res; 2002 Aug; 62(16):4592-8. PubMed ID: 12183413
[TBL] [Abstract][Full Text] [Related]
38. Morphological changes in the hearts of CD1 mice following chronic treatment with doxorubicin and lonidamine.
Sanguedolce R; Flandina C; Cucchiara T; Varvara F; Rausa L
Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):81-9. PubMed ID: 8272575
[TBL] [Abstract][Full Text] [Related]
39. Persistent effects of doxorubicin on cardiac gene expression.
Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
Levey GS; Levey BA; Ruiz E; Lehotay DC
Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
